AzTrials
AzTrials

Behavior, ChildNCT03720028

Angelman & Rett Syndrome: Interaction and Communication

An observational study of Behavior, Child and Parent-Child Relations, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

We aim to describe the communicative and sensory profile of children with Angelman syndrome or Rett syndrome and their use of augmentative and alternative communication. In addition, parents are surveyed regarding parent-child interaction and access to communication support. Read more about this study

Who is it for?
Ages 1 year to 14 years
What is being tested?
Observation and Parental experiences
How many people
20 participants
Where
1 siteBelgium
Study dates
1 Dec 2018to 1 Jul 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Children with complex communication needs.

Who may be able to join

  • Angelman or Rett syndrome

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Katholieke Universiteit Leuven

    Leuven, Vlaams-Brabant, 3000

Other trials in Belgium

About this study

Official title: Parent-child Interaction and Communication in Families Who Have a Child With Rett Syndrome or Angelman Syndrome

We aim to describe the communicative and sensory profile of children with Angelman syndrome or Rett syndrome and their use of augmentative and alternative communication. In addition, parents are surveyed regarding parent-child interaction and access to communication support.

Being tested
Observation, Parental experiences
Medical subject headings
Child Behavior, Communication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ObservationBehavioural

    Describe communication and sensory profile using standardized tests and observations.

  • Parental experiencesBehavioural

    Survey parents' experiences with parent-child interaction and augmentative and alternative communication.

Study groups in NCT03720028
Study groupRoleWhat they receive
Child w Angelman/Rett syndromeChildren with Angelman or Rett syndrome, up to 14 years of age
Receives: Behavioral: Observation
ParentParents of Children with Angelman or Rett syndrome
Receives: Behavioral: Parental experiences

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Communication profile

    Scores on language tests

    Measured: 1 day One-time measurement

  2. Parent interaction

    Scores on social tests

    Measured: 1 day One-time measurement

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2018
  2. Study start1 Dec 2018
  3. Primary completion1 Oct 2019
  4. Study completion1 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03720028
Sponsor's protocol ID
Snummer
Status last verified
Oct 2018
First submitted
23 Oct 2018
Last updated
21 Dec 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Behavior, Child and Parent-Child Relations, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Communication profile (time frame: 1 day One-time measurement). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in